Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) Invested Capital (2023 - 2025)

Upstream Bio has reported Invested Capital over the past 3 years, most recently at $339.8 million for Q4 2025.

  • Quarterly results put Invested Capital at $339.8 million for Q4 2025, down 27.69% from a year ago — trailing twelve months through Dec 2025 was $339.8 million (down 27.69% YoY), and the annual figure for FY2025 was $339.8 million, down 27.69%.
  • Invested Capital for Q4 2025 was $339.8 million at Upstream Bio, down from $378.6 million in the prior quarter.
  • Over the last five years, Invested Capital for UPB hit a ceiling of $469.9 million in Q4 2024 and a floor of -$160.3 million in Q3 2024.
  • Median Invested Capital over the past 3 years was $113.8 million (2023), compared with a mean of $136.7 million.
  • Peak annual rise in Invested Capital hit 481.6% in 2024, while the deepest fall reached 42.87% in 2024.
  • Upstream Bio's Invested Capital stood at -$123.1 million in 2023, then surged by 481.6% to $469.9 million in 2024, then decreased by 27.69% to $339.8 million in 2025.
  • The last three reported values for Invested Capital were $339.8 million (Q4 2025), $378.6 million (Q3 2025), and $408.7 million (Q2 2025) per Business Quant data.